Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces 1000 patients treated with the DETOUR™ System.

See Release

#latest{display:none};2022 News

Archives

Endologix Receives CE Mark Certification under EU MDR for AFX®2 Endovascular AAA System

Endologix Reports 12 Month Data from DETOUR 2 Clinical Trial at 2022 Vascular Annual Meeting